Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Oncolytic and local immunotherapy

Original research

Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study

Online download statistics by month:

Online download statistics by month: December 2022 to November 2024

	Abstract	Full	Pdf
Dec 2022	378	383	105
Jan 2023	264	265	142
Feb 2023	159	161	84
Mar 2023	64	67	46
Apr 2023	60	63	42
May 2023	46	46	26
Jun 2023	43	44	31
Jul 2023	47	47	32
Aug 2023	49	50	26
Sep 2023	45	46	17
Oct 2023	41	42	29
Nov 2023	50	51	21
Dec 2023	42	42	26
Jan 2024	62	63	45
Feb 2024	41	41	28
Mar 2024	59	59	71
Apr 2024	61	61	39
May 2024	53	55	33
Jun 2024	50	52	28
Jul 2024	71	72	36
Aug 2024	26	24	13
Sep 2024	33	33	24
Oct 2024	48	48	23
Nov 2024	41	44	37
Total	1833	1859	1004